Carmell Therapeutics Corp - US shares owned by Vanguard Group
Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Carmell Therapeutics Corp - US
Tip: Access up to 7 years of quarterly data
All positions including Carmell Therapeutics Corp - US held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Carmell Therapeutics Corp - US by Vanguard Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $646k | 170k | 3.81 |
2023-09-30 | $583k | 162k | 3.60 |
Top funds holding Carmell Therapeutics Corp - US
View all funds holding Carmell Therapeutics Corp - US